Could a common drug save sight in diabetic patients?
NCT ID NCT03161652
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether levosulpiride, a drug already used for other conditions, can safely improve vision and reduce retinal swelling in people with diabetic retinopathy and diabetic macular edema. About 120 adults aged 40-69 with mild to moderate eye damage will receive either the drug or a placebo. The goal is to see if it can control the disease and prevent further vision loss.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Instituto Mexicano de Oftalmologia (IMO)
RECRUITINGQuerétaro City, Querétaro, 76090, Mexico
-
Instituto de la Retina del Bajio SC (INDEREB)
RECRUITINGQuerétaro City, Querétaro, 76187, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI eye doctor: could software catch diabetic blindness sooner?
- Can a new eye injection preserve vision in south asians with diabetes?
- Can eye scans reveal hidden clues about diabetes damage?
- Could a biosimilar eye injection offer a new way to treat diabetic macular edema?
- Can a steroid implant boost the effect of standard eye injections for hard-to-treat diabetic macular edema?
- Eye injection aims to tame leading causes of blindness